BC
BIOPOL
Biopol Chemicals
Specialty Chemicals
Share price
₹52
Market cap
₹124 Cr
A specialty chemicals manufacturer engaged in producing silicones, emulsifiers, biochemicals, and polyelectrolytes for diverse industrial applications. Biopol Chemicals operates across multiple chemical segments, serving various end-user industries with formulated chemical solutions and specialty products. The company focuses on manufacturing high-performance biochemical and polymer-based formulations designed for industrial and commercial use across different sectors.
Investors holding Biopol Chemicals
2.31%
1.73%
Recent moves 7
Aikyam CapitalNew position
Aikyam Capital bought 60,000 shares of Biopol Chemicals for ₹64 lakh at ₹107.43 apiece in a bulk deal.
Read more
Craft Emerging MarketsDecreased
Craft Emerging Markets sold 120,000 shares of Biopol Chemicals for ₹1.19 Cr at ₹98.90 apiece in a bulk deal.
Read more
Beacon Stone CapitalDecreased
Beacon Stone Capital sold 118,800 shares of Biopol Chemicals for ₹1.19 Cr at ₹99.89 apiece in a bulk deal. Beacon Stone Capital previously sold 360,000 shares of Biopol Chemicals on February 13, 2026.
Read more
Craft Emerging MarketsDecreased
Craft Emerging Markets decreased its stake in Biopol Chemicals from 5.96% to 1.73%, selling 457,200 shares valued at approximately ₹4.39 crore at ₹96.00 per share. This move represents a significant reduction in their holdings.
Read more
Beacon Stone CapitalDecreased
Beacon Stone Capital decreased its stake in Biopol Chemicals from 3.33% to 2.31%, selling 110,400 shares for ₹1.06 Cr at ₹96.00 apiece.
Read more
Craft Emerging MarketsNew position
Craft Emerging Markets bought 6,44,400 shares of Biopol Chemicals for ₹6.46 Cr at ₹100.25 apiece in an open market transaction, increasing its stake from 0.00% to 5.96% and crossing the 5% disclosure threshold.
Read more
Craft Emerging Marketing Fund PCCNew position
Craft Emerging Marketing Fund PCC acquired 4,01,93,297 shares of Biopol Chemicals for ₹365.76 Cr at ₹91.00 apiece via open market operations, increasing its stake from 0.00% to 6.67% and crossing the 5% disclosure threshold.
Read more